BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

447 related articles for article (PubMed ID: 22142044)

  • 1. Elderly renal transplant recipients and renal dysfunction: a risk factor for hyperuricemia.
    Einollahi B; Einollahi H; Rostami Z
    Exp Clin Transplant; 2011 Dec; 9(6):376-80. PubMed ID: 22142044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyperuricemia in adult renal allograft recipients: prevalence and predictors.
    Malheiro J; Almeida M; Fonseca I; Martins LS; Pedroso S; Dias L; Henriques AC; Cabrita A
    Transplant Proc; 2012 Oct; 44(8):2369-72. PubMed ID: 23026595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum uric acid level is associated with cardiac hypertrophy in renal transplant recipients.
    Caliskan Y; Gorgulu N; Yelken B; Akturk F; Yazici H; Turkmen A; Sever MS
    Clin Transplant; 2011; 25(3):368-74. PubMed ID: 20597927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperuricemia in kidney transplant recipients with intact graft function.
    Kim KM; Kim SS; Han DJ; Yang WS; Park JS; Park SK
    Transplant Proc; 2010 Nov; 42(9):3562-7. PubMed ID: 21094816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Moderate-to-severe early-onset hyperuricaemia: a prognostic marker of long-term kidney transplant outcome.
    Min SI; Yun IJ; Kang JM; Park YJ; Min SK; Ahn C; Kim SJ; Ha J
    Nephrol Dial Transplant; 2009 Aug; 24(8):2584-90. PubMed ID: 19395726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperuricemia is a mediator of endothelial dysfunction and inflammation in renal allograft recipients.
    Karbowska A; Boratynska M; Kusztal M; Klinger M
    Transplant Proc; 2009 Oct; 41(8):3052-5. PubMed ID: 19857674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is uric acid a predictive factor for graft dysfunction in renal transplant recipients?
    Akgul A; Bilgic A; Ibis A; Ozdemir FN; Arat Z; Haberal M
    Transplant Proc; 2007 May; 39(4):1023-6. PubMed ID: 17524881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of hyperuricemia on renal function in pediatric renal transplant recipients.
    Fidan C; Kantar A; Baskın E; Gülleroğlu K; Akdur A; Moray G; Haberal M
    Exp Clin Transplant; 2015 Apr; 13 Suppl 1():247-50. PubMed ID: 25894164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperuricemia and the metabolic syndrome in Hangzhou.
    Cai Z; Xu X; Wu X; Zhou C; Li D
    Asia Pac J Clin Nutr; 2009; 18(1):81-7. PubMed ID: 19329400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors of long-term graft loss in renal transplant recipients with chronic allograft dysfunction.
    Khalkhali HR; Ghafari A; Hajizadeh E; Kazemnejad A
    Exp Clin Transplant; 2010 Dec; 8(4):277-82. PubMed ID: 21143092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of uric acid with inflammation, progressive renal allograft dysfunction and post-transplant cardiovascular risk.
    Bandukwala F; Huang M; Zaltzman JS; Nash MM; Prasad GV
    Am J Cardiol; 2009 Mar; 103(6):867-71. PubMed ID: 19268747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Uric acid as a link between renal dysfunction and both pro-inflammatory and prothrombotic state in patients with metabolic syndrome and coronary artery disease.
    Zapolski T; Waciński P; Kondracki B; Rychta E; Buraczyńska MJ; Wysokiński A
    Kardiol Pol; 2011; 69(4):319-26. PubMed ID: 21523662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Significance of hyperuricemia as a risk factor for developing ESRD in a screened cohort.
    Iseki K; Ikemiya Y; Inoue T; Iseki C; Kinjo K; Takishita S
    Am J Kidney Dis; 2004 Oct; 44(4):642-50. PubMed ID: 15384015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of uric acid in post-renal transplantation hypertension.
    Bandukwala F; Huang M; Prasad GV
    Transplant Proc; 2009 Jun; 41(5):1634-6. PubMed ID: 19545696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of uric acid with risk factors for chronic kidney disease and metabolic syndrome in patients with essential hypertension.
    Seki S; Tsutsui K; Fujii T; Yamazaki K; Anzawa R; Yoshimura M
    Clin Exp Hypertens; 2010; 32(5):270-7. PubMed ID: 20662727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A multicenter study of the association of serum uric acid, serum creatinine, and diuretic use in hypertensive patients.
    Lin CS; Hung YJ; Chen GY; Tzeng TF; Lee DY; Chen CY; Huang WP; Huang CH
    Int J Cardiol; 2011 May; 148(3):325-30. PubMed ID: 20053470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pre-transplant risk factors for renal allograft dysfunction at one year in Indian patients.
    Prabhu R; John GT; Shankar V; Thomas PP; Abi Abraham M; Jeyaseelan L; Jacob CK
    Natl Med J India; 2001; 14(1):18-21. PubMed ID: 11242692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperuricemia as a risk factor for contrast-induced nephropathy in patients with chronic kidney disease.
    Toprak O; Cirit M; Esi E; Postaci N; Yesil M; Bayata S
    Catheter Cardiovasc Interv; 2006 Feb; 67(2):227-35. PubMed ID: 16400673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of cardiovascular risk factors on the outcome of renal transplantation.
    Moghimi M; Falaknazi K; Bagheri N
    Saudi J Kidney Dis Transpl; 2010 May; 21(3):438-42. PubMed ID: 20427865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Uric acid, cardiovascular events and renal dysfunction: a circumstantial connection?].
    Petriş A; Cimpoeşu D; Petriş O; Costache I
    Rev Med Chir Soc Med Nat Iasi; 2012; 116(2):407-12. PubMed ID: 23077928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.